# Community Health Systems Inc: filings

CYH · NYSE · CIK 1108109 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cyh.md) · [Financials](/companies/cyh/financials.md) · [Filings](/companies/cyh/filings.md) · [Insiders](/companies/cyh/insiders.md)

## Reports and events: 424 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 754, 8-K 322, SC 13G/A 82, 10-Q 54, 3 33, 4/A 30, UPLOAD 23, SC 13G 22, CORRESP 20, 10-K 18, DEF 14A 18, S-8 17, SCHEDULE 13G/A 16, DEFA14A 15, 425 11, SC 13D/A 9, 424B5 8, 11-K 6, 144 5, FWP 5, 424B3 4, ARS 4, EFFECT 4, PX14A6G 4, S-3ASR 4, SCHEDULE 13G 4, NO ACT 3, S-4 3, S-8 POS 3, 25-NSE 2, 3/A 2, 8-A12B 2, POSASR 2, PRE 14A 2, S-4/A 2, 10-Q/A 1, 8-K/A 1, CERTNAS 1, CERTNYS 1, S-3 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:30 ET | [10-Q](/filings/0001193125-26-437869.md) | Quarterly report, period 2026-09-30 | 0001193125-26-437869 |
| 2026-10-28 | 16:30 ET | [8-K](/filings/0001193125-26-436229.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436229 |
| 2026-07-23 | 16:30 ET | [10-Q](/filings/0001193125-26-314196.md) | Quarterly report, period 2026-06-30 | 0001193125-26-314196 |
| 2026-07-22 | 16:33 ET | [8-K](/filings/0001193125-26-312454.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312454 |
| 2026-06-01 | 16:30 ET | [8-K](/filings/0001193125-26-251540.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251540 |
| 2026-05-13 | 16:30 ET | [8-K](/filings/0001193125-26-221742.md) | 5.07 Shareholder vote results | 0001193125-26-221742 |
| 2026-05-06 | 16:05 ET | [8-K](/filings/0001193125-26-208926.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-208926 |
| 2026-04-23 | 20:20 ET | [8-K](/filings/0001193125-26-171305.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-171305 |
| 2026-04-22 | 16:30 ET | [10-Q](/filings/0001193125-26-170557.md) | Quarterly report, period 2026-03-31 | 0001193125-26-170557 |
| 2026-04-21 | 16:35 ET | [8-K](/filings/0001193125-26-167000.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-167000 |
| 2026-04-02 | 16:30 ET | [DEF 14A](/filings/0001193125-26-140269.md) | Proxy statement, period 2026-03-31 | 0001193125-26-140269 |
| 2026-04-01 | 16:30 ET | [8-K](/filings/0001193125-26-138026.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-138026 |
| 2026-03-05 | 17:00 ET | [8-K](/filings/0001193125-26-094191.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-094191 |
| 2026-02-19 | 16:32 ET | [10-K](/filings/0001193125-26-059509.md) | Annual report, period 2025-12-31 | 0001193125-26-059509 |
| 2026-02-18 | 16:30 ET | [8-K](/filings/0001193125-26-057162.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-057162 |
| 2026-02-11 | 16:30 ET | [8-K](/filings/0001193125-26-046661.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-046661 |
| 2026-02-02 | 16:30 ET | [8-K](/filings/0001193125-26-033755.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-033755 |
| 2026-01-20 | 16:40 ET | [8-K](/filings/0001193125-26-016693.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-016693 |
| 2025-12-10 | 16:30 ET | [8-K](/filings/0001193125-25-314292.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-314292 |
| 2025-12-02 | 16:44 ET | [8-K](/filings/0001193125-25-305375.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-305375 |
| 2025-10-31 | 17:36 ET | [8-K](/filings/0001193125-25-258896.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-258896 |
| 2025-10-24 | 16:30 ET | [10-Q](/filings/0001193125-25-250030.md) | Quarterly report, period 2025-09-30 | 0001193125-25-250030 |
| 2025-10-23 | 16:32 ET | [8-K](/filings/0001193125-25-248834.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-248834 |
| 2025-09-30 | 17:21 ET | [8-K](/filings/0001193125-25-225272.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-225272 |
| 2025-09-10 | 17:22 ET | [8-K](/filings/0000950170-25-114028.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-114028 |
| 2025-08-12 | 17:22 ET | [8-K](/filings/0001193125-25-179099.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-179099 |
| 2025-07-29 | 21:33 ET | [8-K](/filings/0001193125-25-166943.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-166943 |
| 2025-07-24 | 16:22 ET | [10-Q](/filings/0000950170-25-098357.md) | Quarterly report, period 2025-06-30 | 0000950170-25-098357 |
| 2025-07-23 | 16:18 ET | [8-K](/filings/0000950170-25-097895.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-097895 |
| 2025-07-23 | 16:17 ET | [8-K](/filings/0000950170-25-097894.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-097894 |
| 2025-07-22 | 16:47 ET | [8-K](/filings/0000950170-25-097594.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-097594 |
| 2025-07-01 | 16:30 ET | [8-K](/filings/0000950170-25-092262.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-092262 |
| 2025-05-14 | 16:30 ET | [8-K](/filings/0000950170-25-071500.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-071500 |
| 2025-05-09 | 16:16 ET | [8-K](/filings/0001193125-25-116904.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-116904 |
| 2025-05-07 | 16:26 ET | [8-K](/filings/0001193125-25-114923.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-114923 |
| 2025-04-24 | 16:30 ET | [10-Q](/filings/0000950170-25-058115.md) | Quarterly report, period 2025-03-31 | 0000950170-25-058115 |
| 2025-04-23 | 16:54 ET | [8-K](/filings/0001193125-25-091452.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-091452 |
| 2025-04-23 | 16:47 ET | [8-K](/filings/0001193125-25-091442.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-091442 |
| 2025-04-23 | 16:30 ET | [8-K](/filings/0000950170-25-057457.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-057457 |
| 2025-04-15 | 16:32 ET | [8-K](/filings/0000950170-25-054276.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-054276 |
| 2025-04-03 | 16:30 ET | [DEF 14A](/filings/0000950170-25-050483.md) | Proxy statement, period 2025-04-01 | 0000950170-25-050483 |
| 2025-04-01 | 16:30 ET | [8-K](/filings/0000950170-25-048582.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-048582 |
| 2025-03-03 | 16:30 ET | [8-K](/filings/0000950170-25-030906.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-030906 |
| 2025-02-19 | 16:31 ET | [10-K](/filings/0000950170-25-023242.md) | Annual report, period 2024-12-31 | 0000950170-25-023242 |
| 2025-02-18 | 16:30 ET | [8-K](/filings/0000950170-25-022328.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-022328 |
| 2025-02-14 | 16:30 ET | [8-K](/filings/0000950170-25-021297.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-021297 |
| 2024-12-31 | 16:32 ET | [8-K](/filings/0000950170-24-141627.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-141627 |
| 2024-12-11 | 16:31 ET | [8-K](/filings/0000950170-24-135399.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135399 |
| 2024-11-26 | 16:30 ET | [8-K](/filings/0000950170-24-131062.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-131062 |
| 2024-11-22 | 16:30 ET | [8-K](/filings/0000950170-24-130250.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-130250 |

Page 1 of 9. [Older](/companies/cyh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:46 ET. No prices; not investment advice.